Skip to content

A clinical trial of a therapeutic application ALM-003 for alcohol dependence

A multicenter randomized, open-label trial to assess the efficacy and safety of the digital therapeutics ALM-003 for alcohol dependence

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2032220560
Enrollment
260
Registered
2023-01-07
Start date
2023-02-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol dependence

Interventions

Intervention group: ALM-003 adjunct to treatment as usual for 24 weeks Control group: a simple drink diary app and psychoeducation material adjunct to treatment as usual (enhanced treatment as usual)

Sponsors

So Ryuhei
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We will include people who meet all the following criteria: 1) 20 years of age or older 2) diagnosed with alcohol dependence according to ICD-10 3) High or Very High Drinking Risk Level during screening period (from week -4 to week 0) 4) Can be treated on outpatient clinics 5) No serious social or family problems due to drinking 6) No life-threatening organ failures 7) CIWA-Ar score < 10 at week -4 and week 0 8) Agree to participate in the present study 9) Accustomed to use a smartphone with iOS 14.0 or higher or Android 10 or higher

Exclusion criteria

Exclusion criteria: We will not include people who meet any of the following criteria: 1) < 6 heavy drinking days (HDD) during the screening period 2) 5 consecutive no drinking days during the screening period 3) Diagnosed with dementia or intellectual disability 4) Has participated in any structured treatment for alcohol dependence, structured programs for drinking moderation, or self-help groups during the 4 weeks prior to week -4 5) Concomitant use of medications for alcohol dependence during the 4 weeks prior to week -4 6) Has participated in any intervention study during the 4 weeks prior to week -4 7) Has participated in a preliminary study of the prior version of ALM-003 8) Judged to be at high risk of suicide by investigators or PHQ-9 item 9 (suicidal thoughts) is 1 or more at week -4 9) Female with pregnancy or expecting 10) No fixed address or telephone number 11) Judged to be inappropriate as a participant by investigators

Design outcomes

Primary

MeasureTime frame
Change in HDD from baseline to week 12

Contacts

Public ContactAsuka Shishido

CureApp, Inc

alm-clin-reg@cureapp.jp+81-3-6231-0183

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026